Recombinant Human DEFB130 Protein (Yeast)，His

DEFB130, also known as defensin beta 130, is a member of the defensin family of antimicrobial peptides, which play critical roles in the immune defense of various organisms. These peptides are primarily expressed in epithelial tissues and are known for their capacity to combat a broad spectrum of pathogens, including bacteria, viruses, and fungi. The study of DEFB130 reconstitution has gained interest due to its potential therapeutic implications in enhancing innate immune responses. Research has indicated that DEFB130 not only possesses antimicrobial properties but also modulates immune responses by influencing cell signaling pathways and inflammatory processes. Furthermore, genetic variations in the DEFB130 gene have been associated with various diseases, including autoimmune disorders and infections, highlighting its significance in human health. By producing recombinant DEFB130 protein, scientists aim to further elucidate its biological functions and mechanisms of action, paving the way for developing novel therapeutic strategies aimed at bolstering immune defense or treating immune-related diseases. Understanding the structure-function relationship of this defensin may also provide insights into its potential as a biomarker for disease susceptibility. Overall, the study of DEFB130 is of paramount importance in the fields of immunology and therapeutic development, as it holds promise for advancing our knowledge of host defense mechanisms and their applications in clinical settings.